Skip to content

Abacavir hypersensitivity screening not a substitute for 'clinical vigilance' say investigators at UK's largest HIV clinic

Low CD4 cell count, big drop in viral load, and boosted PI are risk factors for IRIS

Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment

Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment

HIV superinfection in chronically infected patients reported

Raltegravir takes key step towards European approval

Paediatric Kaletra tablet gains formal US approval

Good medium-term outcomes seen in antiretroviral-treated patients in Cambodia

Experts debate how to develop drugs specifically for MDR TB